Table 3 Summary of multivariable logistic regression models assessing the association between plasma neutralizing capacity at T9 and protection against symptomatic and asymptomatic infections over the T9 – T10 period (Jun 2022 – Dec 2022) in vaccinated individuals
From: Determinants of antibody levels and protection against omicron BQ.1/XBB breakthrough infection
Analyte | HR | Lower CI | Upper CI | P-value |
---|---|---|---|---|
D614G | 0.27 | 0.08 | 0.78 | 0.022 |
BA. 1 | 0.32 | 0.10 | 0.90 | 0.036 |
BA. 4. 5 | 0.25 | 0.06 | 0.86 | 0.035 |
BQ. 1. 1 | 0.19 | 0.02 | 1.09 | 0.079 |